These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6409133)

  • 1. [Stability of tablet formulation containing erythromycin ethylsuccinate and demeclocycline hydrochloride].
    Giovinazzo C; Puglisi G; Milazzo L; Caruso A; Mazzone G; Bernardini A
    Boll Chim Farm; 1983 Feb; 122(2):109-17. PubMed ID: 6409133
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of oral suspensions containing sulfonamides in combination with erythromycin ethylsuccinate.
    Elrod L; Cox RD; Plasz AC
    J Pharm Sci; 1982 Feb; 71(2):161-6. PubMed ID: 6977637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinequivalence of erythromycin ethylsuccinate and enteric-coated erythromycin pellets following multiple oral doses.
    Yakatan GJ; Rasmussen CE; Feis PJ; Wallen S
    J Clin Pharmacol; 1985; 25(1):36-42. PubMed ID: 3871797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of universal quantitative models for determination of roxithromycin and erythromycin ethylsuccinate in tablets from different manufacturers using near infrared reflectance spectroscopy.
    Feng YC; Hu CQ
    J Pharm Biomed Anal; 2006 May; 41(2):373-84. PubMed ID: 16406447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal side effects with erythromycin preparations.
    Carter BL; Woodhead JC; Cole KJ; Milavetz G
    Drug Intell Clin Pharm; 1987 Sep; 21(9):734-8. PubMed ID: 3498618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatotoxicity of erythromycin ethylsuccinate in a child.
    Phillips KG
    Can Med Assoc J; 1983 Sep; 129(5):411-2. PubMed ID: 6603894
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatitis due to erythromycin ethylsuccinate].
    Funck-Brentano C; Danan G; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1982 Dec; 6(12):1044-5. PubMed ID: 6984402
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythromycin ethylsuccinate-induced cholestasis.
    Bachman BA; Boyd WP; Brady PG
    Am J Gastroenterol; 1982 Jun; 77(6):397-400. PubMed ID: 6979924
    [No Abstract]   [Full Text] [Related]  

  • 9. [Stability of erythromycin stearate in coated tablets during the action of gastric juice in vitro].
    Pospísilová B; Kubes J
    Cesk Farm; 1987 Mar; 36(2):67-72. PubMed ID: 3581192
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute hepatitis caused by erythromycin esters (propionate and ethylsuccinate)].
    Paliard P; Stremsdoerfer N; Moindrot H
    Gastroenterol Clin Biol; 1983 Jan; 7(1):100-1. PubMed ID: 6601598
    [No Abstract]   [Full Text] [Related]  

  • 11. Erythromycin ethylsuccinate hepatotoxicity.
    Sullivan D; Csuka ME; Blanchard B
    JAMA; 1980 Mar; 243(10):1074. PubMed ID: 6965509
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of group A streptococcal pharyngitis: a randomized controlled study of twice-daily erythromycin ethylsuccinate versus erythromycin estolate.
    Ginsburg CM; McCracken GH; Steinberg JB; Crow SD; Dildy BF; Lancaster K; Olsen K
    Pediatr Infect Dis; 1982; 1(6):384-7. PubMed ID: 6761656
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythromycin-oral anticoagulants interaction.
    Grau E; Fontcuberta J; Félez J
    Arch Intern Med; 1986 Aug; 146(8):1639. PubMed ID: 3488045
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatotoxic reaction to erythromycin ethylsuccinate.
    Patel J; Schneider R
    South Med J; 1984 Oct; 77(10):1343-4. PubMed ID: 6333077
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioavailability and stability of erythromycin delayed release tablets.
    Ogwal S; Xide TU
    Afr Health Sci; 2001 Dec; 1(2):90-6. PubMed ID: 12789122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of erythromycin ethylsuccinate after intragastric administration to healthy foals.
    Lakritz J; Wilson WD; Marsh AE; Mihalyi JE
    Vet Ther; 2002; 3(2):189-95. PubMed ID: 19750750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypothermia associated with erythromycin].
    Cárdenes M; Artiles J; Arkuch A; Suárez S
    Med Clin (Barc); 1992 May; 98(18):715-6. PubMed ID: 1602886
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatotoxicity of erythromycin].
    García Buey L; García-Samaniego Rey J; González Estecha A; Pajares García JM
    Rev Clin Esp; 1989 Feb; 184(3):158. PubMed ID: 2785700
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluorimetric determination of erythromycin and erythromycin ethylsuccinate in serum by a high-performance liquid chromatographic post-column, on-stream derivatization and extraction method.
    Tsuji K
    J Chromatogr; 1978 Oct; 158():337-48. PubMed ID: 721936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of food on absorption of erythromycin ethyl succinate.
    Thompson PJ; Burgess KR; Marlin GE
    Antimicrob Agents Chemother; 1980 Nov; 18(5):829-31. PubMed ID: 6969579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.